Association for Accessible Medicines
FDANonrulemakingFDA-2019-D-0298

Quality Considerations for Continuous Manufacturing; Draft Guidance for Industry

RIN
Last modified
May 26, 2020
Comment window
closed 2542d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between May 30, 2019 and May 30, 2019. 1 other organizations filed here. The comment window closed 2542d ago.

What Association for Accessible Medicines filed (1)

May 30, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2019-D-0298-0018

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2019-D-0298: Quality Considerations for Continuous Manufacturing; Draft Guidance for Industry.

Abstract

OPEN

View on regulations.gov →